SNY

What one share of Sanofi holds

Pharmaceutical Preparations

We apply our deep understanding of the immune system to invent medicines and vaccines that positively impact millions of

Sanofi’s numbers from its SEC filings, divided by its shares. Results cover the latest fiscal year to 2025-12-31; the balance sheet is as of 2025-12-31.

Per-share figures
Profit$3.60
Dividends$2.22
Cash and investments$3.68
Debt$9.00
Book value$34.35

Per share by fiscal year

YearSalesProfitCapexFree cashDividendsBook value
2015—$1.80——$1.58$24.13
2016—$2.01——$1.62$23.60
2017—$3.75——$1.67$27.84
2018—$2.03——$1.79$27.08
2019—$1.23——$1.72$26.44
2020—$5.57——$1.80$30.85
2021—$2.93——$1.89$30.76
2022—$3.51——$1.75$31.73
2023—$2.32——$1.93$32.38
2024—$2.39——$2.03$31.76
2025—$3.60——$2.22$34.35

Common questions about Sanofi

How much does one share of Sanofi earn?

Over its latest fiscal year, each share of Sanofi earned $3.60 of profit.

Does Sanofi pay a dividend?

Yes. Sanofi paid $2.22 per share in dividends over its latest fiscal year, and it paid a dividend in every year from 2015 to 2025 in StockSlicer’s data. That’s about 61¢ of each $1 of profit (payout ratio).

What is Sanofi’s book value per share?

Sanofi’s book value is $34.35 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of December 31, 2025.

How much cash and debt does each share of Sanofi have?

Each share of Sanofi has $3.68 of cash and investments and $9.00 of debt, as of December 31, 2025.

How has Sanofi’s profit per share changed over time?

Profit per share went from $1.80 in 2015 to $3.60 in 2025, growing about 7.2% a year (adjusted for stock splits).

Has Sanofi bought back shares?

Sanofi’s share count fell about 7% from 2015 to 2025. Through buybacks, each remaining share owns a bigger slice of the company.

From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.